Sign In    Register

World Journal of Emergency Medicine ›› 2024, Vol. 15 ›› Issue (1): 47-51.doi: 10.5847/wjem.j.1920-8642.2024.015

• Original Article • Previous Articles     Next Articles

Pulmonary rehabilitation protocols in urgent lung transplantation patients

Fei Zeng, Lingyun Cai, Luyao Guo, Meijuan Lan(), Jiangshuyuan Liang, Peipei Gu   

  1. Nursing Department, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
  • Received:2023-05-26 Accepted:2023-11-20 Online:2023-12-31 Published:2024-01-01
  • Contact: Meijuan Lan E-mail:lanmj@zju.edu.cn

Abstract:

BACKGROUND: Prolonged invasive respiratory support and extracorporeal membrane oxygenation (ECMO) in patients requiring urgent lung transplantation (ULTx) present significant challenges to clinical practice due to severe underlying diseases and complex conditions. The aim of the study was to report the clinical outcomes of patients who received ULTx and followed the perioperative rehabilitation protocol implemented in a lung transplant center.
METHODS: A retrospective analysis was conducted in ULTx patients who required preoperative invasive mechanical ventilation (IMV) and ECMO between January 2018 and January 2023. Data were retrieved from electronic medical records at our lung transplant center.
RESULTS: Fourteen patients (mean age 57.43±10.97 years; 12 males, 2 females) underwent ULTx with bridging ECMO and IMV. The mean body mass index was 23.94±3.33 kg/m², and the mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 21.50±3.96. The Nutritional Risk Screening 2002 (NRS 2002) scores were ≥3. ULTx was performed after an 8.5-day waiting period (interquartile interval [IQR] 5.0-26.5 d). Following the surgeries, the average lengths of ECMO and IMV were 1.0 (IQR 1.0-2.0) d and 5.0 (IQR 3.0-7.3) d, respectively. The total length of hospital stay was 60.1±30.8 d, with an average intensive care unit stay of 38.3±22.9 d and post-operative hospitalization stay of 45.8±26.1 d. Two patients died within 30 d after ULTx, with a 30-day survival rate of 85.71%.
CONCLUSION: Patients receiving ULTx showed an acceptable short-term survival rate, validating the practicality and safety of the treatment protocols implemented in our center.

Key words: Urgent lung transplantation, End-stage lung disease, Extracorporeal membrane oxygenation, Invasive respiratory support, Pulmonary rehabilitation.